Progress in the leukemias.
D000477:Alkylating Agents / Q000627:therapeutic use; D000728:Androgens / Q000627:therapeutic use; D000744:Anemia, Hemolytic, Autoimmune / Q000150:complications; D001554:Benzene / Q000506:poisoning; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation; D002701:Chloramphenicol / Q000009:adverse effects; D002869:Chromosome Aberrations / Q000150:complications; D025063:Chromosome Disorders; D006402:Hematologic Diseases / Q000150:complications; D006801:Humans; D007167:Immunotherapy; D017053:Infection Control; D007621:Karyotyping; D007938:Leukemia / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000532:radiotherapy; D008578:Meninges; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D010357:Patient Isolators; D011830:Radiation Effects; D012190:Retroviridae; D013866:Thioguanine / Q000627:therapeutic use
D000477:Alkylating Agents; D000728:Androgens; D009607:Nitrosourea Compounds; D002701:Chloramphenicol; D013866:Thioguanine; D001554:Benzene